{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:16:09Z","timestamp":1783538169170,"version":"3.55.0"},"reference-count":54,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health","award":["UO1DK108320"],"award-info":[{"award-number":["UO1DK108320"]}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Exocrine pancreatic insufficiency (EPI) is characterized by inadequate pancreatic enzyme delivery to the small intestine Exocrine pancreatic insufficiency (EPI) is characterized by inadequate pancreatic enzyme delivery to the small intestine, resulting in malabsorption. Clinical manifestations of EPI are often nonspecific and can lead to lack of timely recognition and diagnosis. Central to this clinical dilemma is the lack of highly accurate or specific testing which leads to misdiagnosis and suboptimal treatment. Identification of high-risk patients is key in the diagnosis of EPI and this includes patients with pancreatic parenchyma disorders such as chronic pancreatitis, pancreatic malignancy, cystic fibrosis, and those undergoing pancreatic resection for benign and malignant disease. Less recognized are the number of additional conditions which may also have EPI as a consequence. Owing to an increase in morbidity and impaired quality of life associated with this condition, goals of treatment have been aimed at repleting exocrine enzyme deficiency by oral pancreatic enzyme replacement therapy (PERT). The basis of PERT is to provide activated digestive enzymes to the small bowel during the prandial period, mainly, leading to sufficient absorption of fat and fat-soluble vitamins. The benefits of PERT have been shown to go beyond the improvement in signs and symptoms associated with EPI and include decreasing prevalence of osteopathy and improving survival outcomes in subsets of patients with this condition. However, despite the overall benefits in treatment, the diagnosis and management of EPI are suboptimal. Current literature suggests patients at high risk of developing EPI are not tested and those who are diagnosed are not treated with adequate dosages. In this review, we highlight patients who are at high risk for the development of EPI, analyze consequences and treatment of this disorder, review rationale for enzyme replacement therapy, and examine current evidence for treatment optimization.<\/ns4:p>","DOI":"10.12688\/f1000research.20779.1","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:00:10Z","timestamp":1574744410000},"page":"1991","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Update on the diagnosis and management of exocrine pancreatic insufficiency"],"prefix":"10.12688","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6696-1336","authenticated-orcid":false,"given":"Yaseen","family":"Perbtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris E.","family":"Forsmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"2276-86","DOI":"10.1038\/ajg.2010.201","article-title":"Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.","volume":"105","author":"D Whitcomb","year":"2010","journal-title":"Am J Gastroenterol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"181-9","DOI":"10.1016\/j.dld.2004.10.007","article-title":"Quality of life in patients with chronic pancreatitis.","volume":"37","author":"R Pezzilli","year":"2005","journal-title":"Dig Liver Dis."},{"key":"ref-3","first-page":"47-52","article-title":"Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis.","volume":"12","author":"D Borowitz","year":"2007","journal-title":"J Pediatr Pharmacol Ther."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"733-50","DOI":"10.1046\/j.1365-2036.2003.01495.x","article-title":"Review article: Pancreatic function testing.","volume":"17","author":"R Chowdhury","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"241-7","DOI":"10.1097\/MPA.0000000000000434","article-title":"Development and Diagnostic Accuracy of a Breath Test for Pancreatic Exocrine Insufficiency in Chronic Pancreatitis.","volume":"45","author":"J Dom\u00ednguez-Mu\u00f1oz","year":"2016","journal-title":"Pancreas."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"153-99","DOI":"10.1177\/2050640616684695","article-title":"United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).","volume":"5","author":"J L\u00f6hr","year":"2017","journal-title":"United European Gastroenterol J."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"580-5","DOI":"10.1016\/j.pan.2017.03.002","article-title":"Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis: 13C-Mixed Triglyceride Breath Test versus Fecal Elastase.","volume":"17","author":"V Gonz\u00e1lez-S\u00e1nchez","year":"2017","journal-title":"Pancreatology."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"580-6","DOI":"10.1136\/gut.39.4.580","article-title":"Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.","volume":"39","author":"C L\u00f6ser","year":"1996","journal-title":"Gut."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"897-903","DOI":"10.1093\/hmg\/6.6.897","article-title":"Evolutionary silencing of the human elastase I gene (ELA1).","volume":"6","author":"S Rose","year":"1997","journal-title":"Hum Mol Genet."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"e0159363","DOI":"10.1371\/journal.pone.0159363","article-title":"Specificity of a Polyclonal Fecal Elastase ELISA for CELA3.","volume":"11","author":"F Weiss","year":"2016","journal-title":"PLoS One."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1220-1228.e4","DOI":"10.1016\/j.cgh.2018.01.027","article-title":"Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.","volume":"16","author":"R Vanga","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"7059-76","DOI":"10.3748\/wjg.v23.i39.7059","article-title":"Less common etiologies of exocrine pancreatic insufficiency.","volume":"23","author":"V Singh","year":"2017","journal-title":"World J Gastroenterol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"532-40","DOI":"10.1017\/S0007114517000435","article-title":"Malnutrition is associated with increased mortality in older adults regardless of the cause of death.","volume":"117","author":"L S\u00f6derstr\u00f6m","year":"2017","journal-title":"Br J Nutr."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"306-15","DOI":"10.1007\/s11938-018-0186-y","article-title":"Diagnosis and Management of Exocrine Pancreatic Insufficiency.","volume":"16","author":"C Forsmark","year":"2018","journal-title":"Curr Treat Options Gastro."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1282-1291.e3","DOI":"10.1053\/j.gastro.2013.02.008","article-title":"Management of chronic pancreatitis.","volume":"144","author":"C Forsmark","year":"2013","journal-title":"Gastroenterology."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"368-77","DOI":"10.1097\/00006676-198707000-00002","article-title":"Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients.","volume":"2","author":"R Ammann","year":"1987","journal-title":"Pancreas."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"275-80","DOI":"10.1097\/01.mpa.0000437324.52598.ee","article-title":"Smoking as a risk factor for complications in chronic pancreatitis.","volume":"43","author":"M Luaces-Regueira","year":"2014","journal-title":"Pancreas."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"237-43","DOI":"10.1097\/MPA.0000000000000721","article-title":"Pancreatic Insufficiency Secondary to Tobacco Exposure: A Controlled Cross-Sectional Evaluation.","volume":"46","author":"K Raphael","year":"2017","journal-title":"Pancreas."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"1481-7","DOI":"10.1016\/0016-5085(94)90553-3","article-title":"The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis.","volume":"107","author":"P Layer","year":"1994","journal-title":"Gastroenterology."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"226-37","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.","volume":"1","author":"P Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"470-7","DOI":"10.1038\/nrgastro.2009.106","article-title":"Acute pancreatitis: risk of recurrence and late consequences of the disease.","volume":"6","author":"J Sand","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"1985-2005","DOI":"10.1007\/s10620-019-05568-9","article-title":"Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis.","volume":"64","author":"W Huang","year":"2019","journal-title":"Dig Dis Sci."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"253-62","DOI":"10.1016\/j.pan.2018.02.009","article-title":"Pancreatic exocrine insufficiency following acute pancreatitis: Systematic review and study level meta-analysis.","volume":"18","author":"R Hollemans","year":"2018","journal-title":"Pancreatology."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"259-70","DOI":"10.1097\/SLA.0000000000002422","article-title":"New Onset of Diabetes and Pancreatic Exocrine Insufficiency After Pancreaticoduodenectomy for Benign and Malignant Tumors: A Systematic Review and Meta-analysis of Long-term Results.","volume":"267","author":"H Beger","year":"2018","journal-title":"Ann Surg."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"873-85","DOI":"10.1002\/bjs.9136","article-title":"Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy.","volume":"100","author":"C Iacono","year":"2013","journal-title":"Br J Surg."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"53-61","DOI":"10.1016\/j.ando.2017.10.003","article-title":"Predictive factors of endocrine and exocrine insufficiency after resection of a benign tumour of the pancreas.","volume":"79","author":"H Neophytou","year":"2018","journal-title":"Ann Endocrinol (Paris)."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"949-58","DOI":"10.1097\/SLA.0000000000001732","article-title":"Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery.","volume":"264","author":"L Sabater","year":"2016","journal-title":"Ann Surg."},{"key":"ref-28","first-page":"608-16","article-title":"Chronic pancreatitis: long-term surgical results of pancreatic duct drainage, pancreatic resection, and near-total pancreatectomy and islet autotransplantation.","volume":"96","author":"C Morrow","year":"1984","journal-title":"Surgery."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"542-51","DOI":"10.1007\/s10120-017-0757-y","article-title":"Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial.","volume":"21","author":"M Catarci","year":"2018","journal-title":"Gastric Cancer."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1013-20","DOI":"10.1016\/j.dld.2015.06.015","article-title":"Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature.","volume":"47","author":"M Bartel","year":"2015","journal-title":"Dig Liver Dis."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"325-30","DOI":"10.1097\/MPA.0000000000000473","article-title":"Pancreatic Exocrine Insufficiency in Patients With Pancreatic or Periampullary Cancer: A Systematic Review.","volume":"45","author":"D Tseng","year":"2016","journal-title":"Pancreas."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"G459-71","DOI":"10.1152\/ajpgi.00146.2014","article-title":"Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.","volume":"308","author":"A Olivier","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"303-8","DOI":"10.1056\/NEJM199002013220505","article-title":"Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.","volume":"322","author":"D Waters","year":"1990","journal-title":"N Engl J Med."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"1104-10","DOI":"10.1097\/MPA.0000000000000609","article-title":"Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature.","volume":"45","author":"S Mohapatra","year":"2016","journal-title":"Pancreas."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12916-017-0783-y","article-title":"Practical guide to exocrine pancreatic insufficiency - Breaking the myths.","volume":"15","author":"M Struyvenberg","year":"2017","journal-title":"BMC Med."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"559-65","DOI":"10.1016\/j.pan.2018.05.006","article-title":"Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: do we need to treat it? A systematic review.","volume":"18","author":"G Zs\u00f3ri","year":"2018","journal-title":"Pancreatology."},{"key":"ref-37","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.12852.1","article-title":"Chronic pancreatitis: review and update of etiology, risk factors, and management [version 1; peer review: 2 approved].","volume":"7","author":"A Pham","year":"2018","journal-title":"F1000Res."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"238-42","DOI":"10.1016\/j.pan.2013.02.008","article-title":"The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis.","volume":"13","author":"E Sikkens","year":"2013","journal-title":"Pancreatology."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"219-28","DOI":"10.1016\/j.cgh.2013.06.016","article-title":"High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis.","volume":"12","author":"S Duggan","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"11467-85","DOI":"10.3748\/wjg.v20.i33.11467","article-title":"Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century.","volume":"20","author":"T Trang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"360-2","DOI":"10.1016\/j.pan.2018.04.011","article-title":"Chronic pancreatitis and small intestinal bacterial overgrowth.","volume":"18","author":"M DiMagno","year":"2018","journal-title":"Pancreatology."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"379-85","DOI":"10.1016\/j.pan.2018.02.010","article-title":"The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI).","volume":"18","author":"H N\u00ed Chonchubhair","year":"2018","journal-title":"Pancreatology."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"1354-5","DOI":"10.1136\/gutjnl-2016-312529","article-title":"Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.","volume":"66","author":"D de La Iglesia-Garc\u00eda","year":"2017","journal-title":"Gut."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"CD006302","DOI":"10.1002\/14651858.CD006302.pub2","article-title":"Pancreatic enzymes for chronic pancreatitis.","author":"N Shafiq","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"e63-e72","DOI":"10.1097\/MCG.0000000000000917","article-title":"Increased Risk of Mortality Associated With Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis.","volume":"52","author":"D de La Iglesia-Garcia","year":"2018","journal-title":"J Clin Gastroenterol."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12885-018-4439-x","article-title":"Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.","volume":"18","author":"J Dom\u00ednguez-Mu\u00f1oz","year":"2018","journal-title":"BMC Cancer."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"859-67","DOI":"10.1016\/j.hpb.2017.05.009","article-title":"Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.","volume":"19","author":"K Roberts","year":"2017","journal-title":"HPB (Oxford)."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"341-6","DOI":"10.1097\/MPA.0000000000000767","article-title":"The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study.","volume":"46","author":"T Saito","year":"2017","journal-title":"Pancreas."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"133-9","DOI":"10.1016\/j.pan.2013.01.009","article-title":"A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.","volume":"13","author":"H Ramesh","year":"2013","journal-title":"Pancreatology."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"114-21","DOI":"10.1016\/j.pan.2018.10.010","article-title":"Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.","volume":"19","author":"K Roberts","year":"2019","journal-title":"Pancreatology."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"1487-92","DOI":"10.1007\/s11605-012-1927-1","article-title":"The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey: enzyme replacement after surgery.","volume":"16","author":"E Sikkens","year":"2012","journal-title":"J Gastrointest Surg."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"71-3","DOI":"10.1016\/j.pan.2011.12.010","article-title":"Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.","volume":"12","author":"E Sikkens","year":"2012","journal-title":"Pancreatology."},{"key":"ref-53","first-page":"1400","article-title":"Oral pancreatic enzyme replacement therapy (PERT) in patients with pancreatic cancer (PCa) is infrequent and suboptimal: a national level analysis.","volume":"46","author":"C Forsmark","year":"2017","journal-title":"Pancreas."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"S677","DOI":"10.1016\/S0016-5085(17)32382-X","article-title":"Oral Pancreatic Enzyme Replacement Therapy (PERT) in Chronic Pancreatitis (CP) is Infrequent and Often Suboptimal: A National Level Analysis.","volume":"152","author":"C Forsmark","year":"2017","journal-title":"Gastroenterology."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T05:20:15Z","timestamp":1574745615000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":54,"URL":"https:\/\/doi.org\/10.12688\/f1000research.20779.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.22854.r56628","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.22854.r56627","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.22854.r56628, Asbjorn M Drewes, Centre for Pancreatic Diseases & Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark, 26 Nov 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1#referee-response-56628","order":0,"name":"referee-response-56628","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.22854.r56627, Enrique de-Madaria, Servicio de Gastroenterolog\u00eda, Hospital General Universitario de Alicante, Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (ISABIAL-Fundaci\u00f3n FISABIO), Alicante, Spain, 26 Nov 2019, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/8-1991\/v1#referee-response-56627","order":1,"name":"referee-response-56627","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"Chris E. Forsmark receives funding from the National Institute of Health (NIH) UO1DK108320.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}